ClinicaliQ Trial Snapshot
- PERIGON Pivotal Trial — Active Not Recruiting • Non-phase study • NCT02088554.
- PERIGON Trial Summary.
- Study testing whether a new artificial heart valve (Model 400) is safe and effective for patients needing aortic valve replacement.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis. Conditions: Aortic Stenosis Interventions: Model 400 aortic valve bioprosthesis Lead Sponsor: Medtronic Cardiac Surgery Planned Enrollment: 1312 participants